Share on StockTwits
 

Envision Healthcare Holdings (NASDAQ:EVHC) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a report released on Tuesday, Analyst RN reports. They currently have a $38.60 price objective on the stock. Zacks‘ price target indicates a potential upside of 13.60% from the company’s current price.

Several other analysts have also recently commented on the stock. Analysts at Barclays raised their price target on shares of Envision Healthcare Holdings from $33.00 to $39.00 in a research note on Wednesday, January 8th. They now have an “overweight” rating on the stock. Separately, analysts at Jefferies Group raised their price target on shares of Envision Healthcare Holdings from $34.00 to $40.00 in a research note on Wednesday, December 18th. Finally, analysts at KeyCorp initiated coverage on shares of Envision Healthcare Holdings in a research note on Tuesday, December 17th. They set a “buy” rating on the stock. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. The company currently has an average rating of “Buy” and an average price target of $45.88.

Envision Healthcare Holdings (NASDAQ:EVHC) traded up 0.77% during mid-day trading on Tuesday, hitting $34.24. The stock had a trading volume of 190,603 shares. Envision Healthcare Holdings has a one year low of $24.62 and a one year high of $35.55. The stock’s 50-day moving average is $33.45 and its 200-day moving average is $29.95. The company has a market cap of $6.202 billion and a P/E ratio of 447.11.

Envision Healthcare Holdings, Inc, is a provider of physician-led, outsourced medical services in the United States.

To view Zacks’ full report, visit www.zacks.com

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.